AbbVie, Taro settle over rosacea drug patents

27-05-2021

Rory O'Neill

AbbVie, Taro settle over rosacea drug patents

Valeriya Zankovych / Shutterstock.com

AbbVie and its exclusive licensee have settled a patent lawsuit against Taro Pharmaceutical over a generic rosacea drug.


AbbVie, Taro Pharmaceutical Industries, Allergan, rosacea, patents, FDA, generics, Aczone, Evolus, Jeuveau

LSIPR